Q4 2020 Boston Life Science Report

Venture capital flowed into Boston's biotech startups at a record pace. The $1.6 billion raised in Q4 brought the total for the year to $7.6 billion, a 61 percent year-over-year increase. And after a brief dip in the spring, demand shot past pre-COVID levels, ending above 4.5 million s.f. to end 2020, also a new record.

Fill out this form to download report

I would like to receive JLL communications.

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your inquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.